These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11488197)

  • 21. FDA and the quality and integrity of research.
    FDA Consum; 2002; 36(1):4-5. PubMed ID: 11881600
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A; Jones D; Claassens L
    Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FDA's reaction to corporate compliance audits.
    Shroff AP
    Food Drug Law J; 1996; 51(2):221-3. PubMed ID: 11820199
    [No Abstract]   [Full Text] [Related]  

  • 25. US requirements for electronic records and signatures.
    Donawa M
    Med Device Technol; 2000 Nov; 11(9):30-3. PubMed ID: 11146867
    [No Abstract]   [Full Text] [Related]  

  • 26. Product compliance. Drug company to go to trial over faulty AIDS testing kits.
    AIDS Policy Law; 2002 Jul; 17(12):9. PubMed ID: 12134803
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA urged to comply with 1997 Reform Act.
    Fox JL
    Nat Biotechnol; 1998 Oct; 16(10):901-2. PubMed ID: 9788335
    [No Abstract]   [Full Text] [Related]  

  • 28. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.
    Huang SM; Strong JM; Zhang L; Reynolds KS; Nallani S; Temple R; Abraham S; Habet SA; Baweja RK; Burckart GJ; Chung S; Colangelo P; Frucht D; Green MD; Hepp P; Karnaukhova E; Ko HS; Lee JI; Marroum PJ; Norden JM; Qiu W; Rahman A; Sobel S; Stifano T; Thummel K; Wei XX; Yasuda S; Zheng JH; Zhao H; Lesko LJ
    J Clin Pharmacol; 2008 Jun; 48(6):662-70. PubMed ID: 18378963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meeting US and European supplier control requirements.
    Donawa M
    Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [State surveillance and control of food quality and safety in USA].
    Berman VA
    Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. U.S. Food and Drug Administration inspections of clinical investigators: overview of results from 1977 to 2009.
    Morgan-Linnell SK; Stewart DJ; Kurzrock R
    Clin Cancer Res; 2014 Jul; 20(13):3364-70. PubMed ID: 24737548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foreign Establishment Registration and United States agent requirements.
    Nolte CJ; McNamara-Cullinane M
    Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-clinical development of cancer vaccines: regulatory considerations.
    Chabicovsky M; Ryle P
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):226-37. PubMed ID: 16460857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The US medical device bundling policy.
    Donawa M
    Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US importer and distributor requirements.
    Donawa M
    Med Device Technol; 2005 Jun; 16(5):25-7. PubMed ID: 15984543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.